Search bioRxiv⌕ Search

Biology subjects

Noerrelykke, S.

Publications and source records attributed to Noerrelykke, S..

2 recordsLinked to original sources

Kidney Tissue Characterization using Normalized Raman Imaging and Segment-Anything

Normalized Raman Imaging (NoRI) enables high-resolution, label-free quantification of protein and lipid concentrations in biological tissues. Because NoRI provides rich molecular information, the analysis of its large, multi-channel datasets turns into a significant computational bottleneck. In this work, we introduce a novel, modular computational pipeline for automated segmentation and quantification of kidney tissue structures imaged with NoRI. The pipeline integrates classical image processing with state-of-the-art machine learning tools, including the Segment Anything Model (SAM) and ilastik, to segment key anatomical and biochemical features--such as tubules, nuclei, brush borders, and lumens. A custom contrast-enhancement strategy was developed to create a third SAM input channel from NoRI data, leading to a substantial improvement in segmentation performance (F1 score: 0.9226). Our framework enables accurate cytoplasm, resolved quantification of protein and lipid concentrations and reveals distinct biochemical signatures across renal tubule subtypes and experimental conditions. This method offers a robust, scalable foundation for quantitative tissue analysis and enhances the utility of NoRI imaging for biomedical research.

bioinformatics↗

An Fc-SPINK1 fusion protein inhibits pancreatic inflammation in a mouse model

Pancreatitis results from premature activation and impaired inactivation of pancreatic proteases, primarily trypsin, leading to self-digestion, tissue necrosis, fibrosis, and inflammation. SPINK1 is a pancreas-specific inhibitor of trypsin that prevents premature trypsin activation, and could be a candidate therapeutic. However, because of its small size, SPINK1 would be subject to rapid renal clearance, making it ineffective. To construct a long half-life therapeutic inhibitor of trypsin for pancreatitis treatment we fused this protein to the C-terminus of an IgG1 antibody Fc element, increasing the size to [~]78 kDa, thereby exceeding the renal clearance threshold and providing for FcRn-mediated recycling out of cells. A non-glycosylated form of Fc-SPINK1 was expressed in the yeast Pichia pastoris. Fc-SPINK1 inhibits trypsin enzyme activity in vitro. The blood pharmacokinetics in mice are consistent with a three-compartment distribution model and a terminal half-life of [~]3 days. In a caerulein-induced mouse model of pancreatitis, Fc-SPINK1 significantly ameliorated cell death and immune cell infiltration. We developed an automated image analysis technique to quantify pancreatitis-associated loss of tissue cohesion, and found that Fc-SPINK1 also reduced this effect. This study demonstrates the potential of Fc-SPINK1 as a rationally designed therapy for pancreatitis.

pharmacology and toxicology↗